|Report ID : RC-51268||Category : Pharmaceuticals|
|Published Date : Oct-19||Pages : 107||Format : PDF|
The global Glucagon market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Glucagon from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Glucagon market. Leading players of Glucagon including: Novo Nordisk Eli Lilly Fresenius Kabi Torrent Labs Taj Pharmaceuticals Xeris Pharmaceuticals ... Market split by Type, can be divided into: Inject Glucagon Nasal Glucagon Market split by Application, can be divided into: Emergency Kits General Use Diagnostic & Motility Cardiogenic Shock Others Market split by Sales Channel, can be divided into: Direct Channel Distribution Channel Market segment by Region/Country including: North America (United States, Canada and Mexico) Europe (Germany, UK, France, Italy, Russia and Spain etc.) Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) South America Brazil, Argentina, Colombia and Chile etc.) Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.) If you have any special requirement, please let us know and we can provide you the report as your requirement.
Table of Contents Chapter 1 Glucagon Market Overview 1.1 Glucagon Definition 1.2 Global Glucagon Market Size Status and Outlook (2013-2028) 1.3 Global Glucagon Market Size Comparison by Region (2013-2028) 1.4 Global Glucagon Market Size Comparison by Type (2013-2028) 1.5 Global Glucagon Market Size Comparison by Application (2013-2028) 1.6 Global Glucagon Market Size Comparison by Sales Channel (2013-2028) 1.7 Glucagon Market Dynamics 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/ Expansion) Chapter 2 Glucagon Market Segment Analysis by Player 2.1 Global Glucagon Sales and Market Share by Player (2016-2018) 2.2 Global Glucagon Revenue and Market Share by Player (2016-2018) 2.3 Global Glucagon Average Price by Player (2016-2018) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Glucagon Market Segment Analysis by Type 3.1 Global Glucagon Market by Type 3.1.1 Inject Glucagon 3.1.2 Nasal Glucagon 3.2 Global Glucagon Sales and Market Share by Type (2013-2018) 3.3 Global Glucagon Revenue and Market Share by Type (2013-2018) 3.4 Global Glucagon Average Price by Type (2013-2018) 3.5 Leading Players of Glucagon by Type in 2018 3.6 Conclusion of Segment by Type Chapter 4 Glucagon Market Segment Analysis by Application 4.1 Global Glucagon Market by Application 4.1.1 Emergency Kits 4.1.2 General Use 4.1.3 Diagnostic & Motility 4.1.4 Cardiogenic Shock 4.1.5 Others 4.2 Global Glucagon Sales and Market Share by Application (2013-2018) 4.3 Leading Consumers of Glucagon by Application in 2018 4.4 Conclusion of Segment by Application Chapter 5 Glucagon Market Segment Analysis by Sales Channel 5.1 Global Glucagon Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Glucagon Sales and Market Share by Sales Channel (2013-2018) 5.3 Leading Distributors/Dealers of Glucagon by Sales Channel in 2018 5.4 Conclusion of Segment by Sales Channel Chapter 6 Glucagon Market Segment Analysis by Region 6.1 Global Glucagon Market Size and CAGR by Region (2013-2028) 6.2 Global Glucagon Sales and Market Share by Region (2013-2018) 6.3 Global Glucagon Revenue and Market Share by Region (2013-2018) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Glucagon Market Share by Type 6.4.3 North America Glucagon Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Glucagon Market Share by Type 6.5.3 Europe Glucagon Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Glucagon Market Share by Type 6.6.3 Asia-Pacific Glucagon Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Glucagon Market Share by Type 6.7.3 South America Glucagon Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.7.7 Chile 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Glucagon Market Share by Type 6.8.3 Middle East & Africa Glucagon Market Share by Application 6.8.4 Egypt 6.8.5 Saudi Arabia 6.8.6 South Africa 6.8.7 Nigeria 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Glucagon Players 7.1 Novo Nordisk 7.1.1 Company Snapshot 7.1.2 Product/Business Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 Strategy and SWOT Analysis 7.2 Eli Lilly 7.3 Fresenius Kabi 7.4 Torrent Labs 7.5 Taj Pharmaceuticals 7.6 Xeris Pharmaceuticals Chapter 8 Upstream and Downstream Analysis of Glucagon 8.1 Industrial Chain of Glucagon 8.2 Upstream of Glucagon 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Glucagon 8.3.1 Leading Distributors/Dealers of Glucagon 8.3.2 Leading Consumers of Glucagon Chapter 9 Development Trend of Glucagon (2019-2028) 9.1 Global Glucagon Market Size (Sales and Revenue) Forecast (2019-2028) 9.2 Global Glucagon Market Size and CAGR Forecast by Region (2019-2028) 9.3 Global Glucagon Market Size and CAGR Forecast by Type (2019-2028) 9.4 Global Glucagon Market Size and CAGR Forecast by Application (2019-2028) 9.5 Global Glucagon Market Size Forecast by Sales Channel (2019-2028) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification
KS 66213, USA